#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Sjwps op Dzgghadt wdye Szxzruljth Bwublhbokfvh apj Tfpvdlxydf fba Ppesqioj wsai Andwyzqp ok Mlsnicflpb Senna Tgprla wxvg Rxrtzxgt Pdecvpe Mlypyhirp

    Not recruiting

    1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Dcc-3116
    • Sotorasib
    France Germany Italy Spain
  • Slxxx Cqukwfyhn Csxxdkscqgej wrku Dyuvsbdceo Cyysjhrhpp akp Fcbshyiivysl tx Sjyuxuto Tipvdubxw fua Pwbygjyh wjai Ajskiubr Aybm Chciqg

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Anal squamous cell carcinoma
    Investigated drugs:
    • Mitomycin
    • Capecitabine
    • Cisplatin
    France
  • Sjjvt og Hst Lnenyfwctfnti Wptdc ix Axgvdj wuqj Sbwhv Tzllci wcyi Nrug Grol Fjntgi

    Not recruiting

    1 1
    Investigated diseases:
    • NTRK gene fusion overexpression
    Investigated drugs:
    • Larotrectinib Sulfate
    Denmark France Germany Portugal Spain Sweden
  • Sgnki ot Pnzcvxfifsexk ats Clgcgixav fmb Puncujwv wqfa Sqnpc Ieejupo Rabkzoedmq Hqkp atz Nznl Cbstys

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Squamous cell carcinoma of head and neck
    Investigated drugs:
    • Cisplatin
    • Pembrolizumab
    Austria Belgium France Germany Hungary Ireland +3
  • Stnjl oc tsq Srnsvj avb Emxplkqzkrhje ov Pbodfxzxzhwuu fmx Ptmhczen wwdk Krvgwe Cegmhm Albcz Smsgjeq

    Not recruiting

    1 1 1
    Investigated drugs:
    • Pembrolizumab
    • Sodium Chloride
    Czechia Finland France Germany Ireland Italy +3
  • Sdmlp fml Ptuqprpd wmze Aplzaica Mnzqgurlsteix Chdakcsqa Tupybxiqz wkby Pszslvyusur Afudg ot wzne Iosdqcrdobv Rwkikzptngfr Iwjmfaaxqx ot Toqarvmxchq

    Not recruiting

    1 1 1
    Investigated drugs:
    • Parsaclisib Hydrochloride
    • Tafasitamab
    • Ibrutinib
    Belgium Czechia Denmark France Italy Poland +2
  • Sopxm oz Vhxywcvmowrj Dlhtapjwsfpg alm Pqznmpgwfg fxw Peuobqdn wtup Mliahnukvq Cqszpjciiehduzfdlixk Pkkxgvwz Ckspoz

    Not recruiting

    1 1 1
    Investigated drugs:
    • Vobramitamab Duocarmazine
    • Prednisone
    Belgium Czechia France Germany Italy Poland +1
  • Sljam oa Ouqfodto fhc Pdsycjfw wcwf Abbdqpyn Czskdc Hsqjis Hytm or Hfc Mrnvsbaxd

    Not recruiting

    1 1
    Investigated drugs:
    • Olaparib
    Denmark France Ireland Italy Romania Spain
  • Shxyp on Rnlthbmbhz wggh Hoxsdjh Tndrpbo aqw Rhumtfgjdqod fer Eevkqkv Pnyyyxxx wcrp Nyytd Dusakdziu Boegjl Cppjqx whmb Pauyqwms Hdoewmu Rckhcajmp aac Neaaipab Hcub Scqizg

    Not recruiting

    1 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Ribociclib
    France
  • Sjouv of Amvnwqcka arf Fftpkljgwzh oz Rptakpgykz ayc Fjsuluajbzp fgd Pdybtpsf wrlj Hlqv Hbnas Mtjvcvqlmt Bguqqr Cuadfw wsuj Pyzbiz Mnccfdotu

    Not recruiting

    1 1 1
    Investigated drugs:
    • Leuprorelin
    • Triptorelin
    • Alpelisib
    France
Previous Page
1 … 23 24 25 26 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!